Prognostic role of PET/MRI hybrid imaging in patients with pulmonary arterial hypertension.
Remigiusz KazimierczykPiotr SzumowskiStephan G NekollaPiotr BlaszczakLukasz A MalekBarbara Milosz-WieczorekJolanta MiskoDorota JurgilewiczMarcin HladunskiMalgorzata KnappBozena SobkowiczJanusz MysliwiecRyszard GrzywnaWlodzimierz J MusialKarol Adam KamińskiPublished in: Heart (British Cardiac Society) (2020)
Increased RV glucose uptake in PET and decreased RVEF identify patients with PAH with worse prognosis. Combining parameters from PET and MRI may help to identify patients at higher risk who potentially benefit from therapy escalation, but this hypothesis requires prospective validation.
Keyphrases
- pulmonary arterial hypertension
- computed tomography
- pet ct
- positron emission tomography
- contrast enhanced
- magnetic resonance imaging
- pulmonary artery
- pet imaging
- pulmonary hypertension
- mycobacterium tuberculosis
- high resolution
- diffusion weighted imaging
- type diabetes
- stem cells
- magnetic resonance
- open label
- clinical trial
- randomized controlled trial
- metabolic syndrome
- bone marrow
- fluorescence imaging